Furthermore, no evidence-based
One appealing candidate is minocycline, a relatively safe and inexpensive synthetic tetracycline that crosses the blood–brain barrier
Minocycline has immunomodulatory and neuroprotective activities in vitro and in an animal model of multiple sclerosis (MS)
MS: multiple sclerosis, MIN: minocycline, APC: antigen presenting cells, MMPs: matrix metalloproteinases, BBB: blood–brain barrier, CNS: central nervous system, MHCII:
The high cost of current treatments1 has
DALLAS – Feb
Minocycline treatment exerted positive effects in Minocycline has immunomodulatory and neuroprotective activities in vitro and in an animal model of multiple sclerosis (MS)
A common antibiotic may be of use in the treatment of multiple sclerosis according to a new study
An occasional fast + clemastine fumarate Furthermore, no evidence-based guidelines were identified regarding minocycline for relapsing-remitting multiple sclerosis or clinically isolated syndrome
Multiple sclerosis is characterized by the infiltration of leukocytes into the CNS
2017 Aug 24;377(8):788-789
The efficacy of ocrelizumab in reducing relapse rates and disease activity in patients with RMS was
15, Issue
doi: 10